消炎利胆片辅助腹腔镜胆囊切除术治疗急性结石性胆囊炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R575.6+1

基金项目:


Clinical Study on Xiaoyan Lidan Tablets Assisting Laparoscopic Cholecystectomy for Acute Calculous Cholecystitis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察消炎利胆片辅助腹腔镜胆囊切除术治疗急性结石性胆囊炎的临床疗效及其对血清超 敏C-反应蛋白(hs-CRP)、降钙素原(PCT) 水平的影响。方法:选择行腹腔镜胆囊切除术的急性结石性胆囊 炎患者78 例作回顾性分析,根据治疗方式的不同分为对照组和观察组各39 例。对照组采用腹腔镜胆囊切除术 治疗,观察组在腹腔镜胆囊切除术治疗的基础上加用消炎利胆片治疗。比较2 组临床疗效、术后症状改善时 间、不良反应发生率和治疗前后中医证候评分、hs-CRP、PCT 水平。结果:观察组总有效率为94.87%,对照 组为79.48%,2 组比较,差异有统计学意义(P<0.05)。观察组肠鸣音恢复时间、首次排气时间、首次排便时 间、住院时间均较对照组短,差异有统计学意义(P<0.05)。治疗后,2 组上腹疼痛、压痛、晨起口苦、恶心 呕吐、持续低热、身目黄染、舌红苔黄等中医证候评分均较治疗前降低(P<0.05),且观察组各项中医证候评 分均低于对照组(P<0.05)。治疗后,观察组血清hs-CRP、PCT 水平均低于治疗前及对照组(P<0.05),而 对照组上述2 项指标治疗前后差异均无统计学意义(P>0.05)。观察组不良反应发生率为7.69%,对照组为 20.51%,2 组比较,差异无统计学意义(P>0.05)。结论:消炎利胆片联合腹腔镜胆囊切除术治疗急性结石性 胆囊炎可提高临床疗效,显著降低中医证候评分和不良反应发生率,缩短术后胃肠功能恢复时间,下调血清 hs-CRP、PCT 水平,且安全性较高。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Xiaoyan Lidan Tablets assisting laparoscopic cholecystectomy on acute calculous cholecystitis and its effect on high- sensitive C- reactive protein (hs- CRP) and the level of procalcitonin (PCT). Methods: A total of 78 patients with acute calculous cholecystitis treated with laparoscopic cholecystectomy were analyzed retrospectively and divided into the control group and the observation group according to different treatment methods,with 39 cases in each group. The control group was given the laparoscopic cholecystectomy, and the observation group was additionally treated with oral administration of Xiaoyan Lidan Tablets based on the treatment of the control group. The clinical effects,improvement time of symptoms after surgery,incidence of adverse reactions as well as the traditional Chinese medicine (TCM) syndrome scores and levels of hs- CRP and PCT were compared between the two groups before and after treatment. Results: The total effective rate was 94.87% in the observation group,and 79.48% in the control group,the difference being significant (P< 0.05). The recovery time of bowel sound,first exhaust time,first defecation time and hospitalization time in the observation group were shorter than those in the control group,the difference being significant (P< 0.05). After treatment,the TCM syndrome scores of pain in upper abdomen,tenderness,bitter taste in the morning,nausea and vomiting,continuous low-grade fever,yellow skin and eyes,and red tongue and yellow coating in both groups were decreased when compared with those before treatment (P<0.05), and the above seven scores in the observation group were lower than those in the control group (P<0.05). After treatment, the levels of hs- CRP and PCT in the observation group were lower than those in the control group and before treatment (P<0.05), and there was no significant difference being found in the comparisons of above two indexes in the control group before and after treatment (P>0.05). The incidence of adverse reactions was 7.69% in the observation group,and 20.51% in the control group,there being no significance in the difference (P>0.05). Conclusion: Xiaoyan Lidan Tablets combined with laparoscopic cholecystectomy for acute calculous cholecystitis can enhance the curative effect, shorten the recovery time of gastrointestinal function,and decrease the levels of hs-CRP and PCT,with better safety.

    参考文献
    相似文献
    引证文献
引用本文

陈周明,张坤,谭炜,张胜娟.消炎利胆片辅助腹腔镜胆囊切除术治疗急性结石性胆囊炎临床研究[J].新中医,2023,55(8):100-104

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-04-25
  • 出版日期:
文章二维码